141 related articles for article (PubMed ID: 3143013)
1. Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection.
Ward KH; Anwar H; Brown RW; Wale J; Gowar J
J Med Microbiol; 1988 Nov; 27(3):179-90. PubMed ID: 3143013
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection.
Cochrane DM; Brown MR; Anwar H; Weller PH; Lam K; Costerton JW
J Med Microbiol; 1988 Dec; 27(4):255-61. PubMed ID: 3143837
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infection.
Shand GH; Pedersen SS; Brown MR; Høiby N
J Med Microbiol; 1991 Apr; 34(4):203-12. PubMed ID: 1902261
[TBL] [Abstract][Full Text] [Related]
4. Role of IgG subclass response to outer-membrane proteins in inhibiting adhesion of Pseudomonas aeruginosa to epithelial cells.
Morrin M; Reen DJ
J Med Microbiol; 1993 Dec; 39(6):467-72. PubMed ID: 8246267
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
Gnehm HE; Pelton SI; Gulati S; Rice PA
J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
[TBL] [Abstract][Full Text] [Related]
6. Immune response in cystic fibrosis to outer membrane proteins of Pseudomonas aeruginosa.
Kubesch P; von Specht BU; Tümmler B
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):395-410. PubMed ID: 3146171
[TBL] [Abstract][Full Text] [Related]
7. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
[TBL] [Abstract][Full Text] [Related]
8. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis.
Aronoff SC; Stern RC
J Infect Dis; 1988 May; 157(5):934-40. PubMed ID: 2452219
[TBL] [Abstract][Full Text] [Related]
11. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations.
Holder IA; Naglich JG
J Trauma; 1986 Feb; 26(2):118-22. PubMed ID: 2418208
[TBL] [Abstract][Full Text] [Related]
12. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
Matthews-Greer JM; Gilleland HE
J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
[TBL] [Abstract][Full Text] [Related]
13. Conformation-dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans.
Lee N; Ahn B; Jung SB; Kim YG; Kim H; Park WJ
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):79-85. PubMed ID: 10617794
[TBL] [Abstract][Full Text] [Related]
14. [Dynamics of humoral antibody formation against the O-antigen of Pseudomonas aeruginosa in suppurative diseases].
Zarubina EK; Svetukhin AM; Edvabnaia LS
Khirurgiia (Mosk); 1980 Nov; (11):47-52. PubMed ID: 6777579
[No Abstract] [Full Text] [Related]
15. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.
Aronoff SC; Quinn FJ; Stern RC
Pediatr Pulmonol; 1991; 11(4):289-93. PubMed ID: 1722035
[TBL] [Abstract][Full Text] [Related]
16. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
17. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
Collins MS; Ladehoff DK; Mehton NS; Noonan JS
FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
19. Antibody response of infected mice to outer membrane proteins of Pseudomonas aeruginosa.
Hedstrom RC; Pavlovskis OR; Galloway DR
Infect Immun; 1984 Jan; 43(1):49-53. PubMed ID: 6418663
[TBL] [Abstract][Full Text] [Related]
20. Human immune response to the 18-kDa outer-membrane antigen of Vibrio cholerae.
Sciortino CV
J Med Microbiol; 1993 Aug; 39(2):135-40. PubMed ID: 8345508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
